Ista Pharmaceuticals Stock Shares Owned By Institutions
Ista Pharmaceuticals fundamentals help investors to digest information that contributes to Ista Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Ista Stock. The fundamental analysis module provides a way to measure Ista Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ista Pharmaceuticals stock.
Ista |
Ista Pharmaceuticals Company Shares Owned By Institutions Analysis
Ista Pharmaceuticals' Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Current Ista Pharmaceuticals Shares Owned By Institutions | 78.10 % |
Most of Ista Pharmaceuticals' fundamental indicators, such as Shares Owned By Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ista Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
CompetitionBased on the latest financial disclosure, 78% of Ista Pharmaceuticals are shares owned by institutions. This is much higher than that of the sector and significantly higher than that of the Pharmaceutical Products industry. The shares owned by institutions for all United States stocks is notably lower than that of the firm.
Ista Shares Owned By Institutions Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ista Pharmaceuticals' direct or indirect competition against its Shares Owned By Institutions to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ista Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Ista Pharmaceuticals by comparing valuation metrics of similar companies.Ista Pharmaceuticals is currently under evaluation in shares owned by institutions category among related companies.
Ista Fundamentals
Return On Asset | -0.41 | |||
Profit Margin | (0.35) % | |||
Operating Margin | (0.29) % | |||
Current Valuation | 305.65 M | |||
Shares Outstanding | 38.61 M | |||
Shares Owned By Insiders | 10.68 % | |||
Shares Owned By Institutions | 78.10 % | |||
Number Of Shares Shorted | 4.81 M | |||
Price To Earning | 38.19 X | |||
Price To Book | (5.96) X | |||
Price To Sales | 2.42 X | |||
Revenue | 160.33 M | |||
Gross Profit | 121.22 M | |||
EBITDA | (47.03 M) | |||
Net Income | (56.61 M) | |||
Cash And Equivalents | 71.59 M | |||
Cash Per Share | 1.28 X | |||
Total Debt | 67.69 M | |||
Debt To Equity | (4.12) % | |||
Current Ratio | 1.02 X | |||
Cash Flow From Operations | (3.49 M) | |||
Short Ratio | 8.30 X | |||
Earnings Per Share | 0.24 X | |||
Price To Earnings To Growth | 1.03 X | |||
Number Of Employees | 330 | |||
Beta | 2.63 | |||
Market Capitalization | 292.58 M | |||
Total Asset | 153.09 M | |||
Retained Earnings | (459.18 M) | |||
Working Capital | 2.27 M | |||
Current Asset | 140.12 M | |||
Current Liabilities | 137.85 M | |||
Z Score | 0.6 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ista Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ista Pharmaceuticals' short interest history, or implied volatility extrapolated from Ista Pharmaceuticals options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in Ista Stock
If you are still planning to invest in Ista Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ista Pharmaceuticals' history and understand the potential risks before investing.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Transaction History View history of all your transactions and understand their impact on performance | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |